• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激肽释放酶6促进胃癌细胞的生长、迁移和侵袭。

KLK6 Promotes Growth, Migration, and Invasion of Gastric Cancer Cells.

作者信息

Zhu Shengxing, Shi Jihua, Zhang Shanfeng, Li Zhen

机构信息

Department of Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Department of The Second General Surgery, People's Hospital of Zhengzhou, Zhengzhou, China.

出版信息

J Gastric Cancer. 2018 Dec;18(4):356-367. doi: 10.5230/jgc.2018.18.e35. Epub 2018 Nov 14.

DOI:10.5230/jgc.2018.18.e35
PMID:30607299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6310766/
Abstract

PURPOSE

Kallikrein (KLK) proteases are hormone-like signaling molecules with critical functions in different cancers. This study investigated the expression of KLK6 in gastric cancer and its potential role in the growth, migration, and invasion of gastric cancer cells.

MATERIALS AND METHODS

In this study, we compared protein levels of KLK6, vascular endothelial growth factor (VEGF), and matrix metallopeptidase (MMP) 9 in normal gastric epithelial and gastric cancer cell lines by western blot. Fluorescence-activated cell sorting was employed to sort 2 clones of SGC-7901 cells with distinct KLK6 expression, namely, KLK6-high (KLK6) and KLK6-low (KLK6), which were then expanded. Lastly, immunohistochemical analysis was performed to investigate KLK6 expression in gastric cancer patients.

RESULTS

The expression levels of KLK6, VEGF, and MMP 9, were significantly higher in the gastric cancer cell lines SGC-7901, BGC-823, MKN-28, and MGC-803 than in the normal gastric epithelial cell line GES-1. Compared to KLK6 cells, KLK6 cells showed enhanced viability, colony-forming ability, migration, and invasion potential in vitro. Importantly, immunohistochemical analysis of a human gastric cancer tissue cohort revealed that the staining for KLK6, VEGF, and MMP9 was markedly stronger in the cancerous tissues than in the adjacent normal tissues. KLK6 expression also correlated with that of VEGF and MMP9 expression, as well as several key clinicopathological parameters.

CONCLUSIONS

Together, these results suggest an important role for KLK6 in human gastric cancer progression.

摘要

目的

激肽释放酶(KLK)蛋白酶是一类激素样信号分子,在不同癌症中发挥关键作用。本研究旨在调查KLK6在胃癌中的表达及其在胃癌细胞生长、迁移和侵袭中的潜在作用。

材料与方法

在本研究中,我们通过蛋白质印迹法比较了正常胃上皮细胞系和胃癌细胞系中KLK6、血管内皮生长因子(VEGF)和基质金属蛋白酶(MMP)9的蛋白水平。采用荧光激活细胞分选技术对SGC-7901细胞中KLK6表达不同的两个克隆进行分选,即KLK6高表达(KLK6)和KLK6低表达(KLK6),然后进行扩增。最后,通过免疫组织化学分析研究KLK6在胃癌患者中的表达情况。

结果

胃癌细胞系SGC-7901、BGC-823、MKN-28和MGC-803中KLK6、VEGF和MMP 9的表达水平显著高于正常胃上皮细胞系GES-1。与KLK6细胞相比,KLK6细胞在体外表现出更强的活力、集落形成能力、迁移和侵袭潜力。重要的是,对一组人胃癌组织的免疫组织化学分析显示,癌组织中KLK6、VEGF和MMP9的染色明显强于相邻正常组织。KLK6表达还与VEGF和MMP9表达以及几个关键临床病理参数相关。

结论

这些结果共同表明KLK6在人类胃癌进展中起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e59/6310766/a0a0e666f0e4/jgc-18-356-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e59/6310766/0c1336828447/jgc-18-356-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e59/6310766/d703e285d761/jgc-18-356-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e59/6310766/866a8f346181/jgc-18-356-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e59/6310766/c8a709ff8099/jgc-18-356-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e59/6310766/a0a0e666f0e4/jgc-18-356-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e59/6310766/0c1336828447/jgc-18-356-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e59/6310766/d703e285d761/jgc-18-356-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e59/6310766/866a8f346181/jgc-18-356-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e59/6310766/c8a709ff8099/jgc-18-356-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e59/6310766/a0a0e666f0e4/jgc-18-356-g005.jpg

相似文献

1
KLK6 Promotes Growth, Migration, and Invasion of Gastric Cancer Cells.激肽释放酶6促进胃癌细胞的生长、迁移和侵袭。
J Gastric Cancer. 2018 Dec;18(4):356-367. doi: 10.5230/jgc.2018.18.e35. Epub 2018 Nov 14.
2
Silencing of kallikrein-related peptidase 6 attenuates the proliferation, migration, and invasion of gastric cancer cells through inhibition of epithelial-mesenchymal transition.激肽释放酶相关肽酶6的沉默通过抑制上皮-间质转化减弱胃癌细胞的增殖、迁移和侵袭。
Exp Ther Med. 2021 Jul;22(1):770. doi: 10.3892/etm.2021.10202. Epub 2021 May 17.
3
Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer.激肽释放酶6在人胃癌中过表达的临床病理及生物学意义
Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6800-6. doi: 10.1158/1078-0432.CCR-05-0943.
4
[Infection with L-form of Helicobacter pylori and expressions of MIF, MMP9 and VEGF in gastric carcinoma].[幽门螺杆菌L型感染与胃癌中巨噬细胞移动抑制因子、基质金属蛋白酶9和血管内皮生长因子的表达]
Nan Fang Yi Ke Da Xue Xue Bao. 2014 Feb;34(2):180-7.
5
KLK6 mediates stemness and metabolism of gastric carcinoma cells via the PI3K/AKT/mTOR signaling pathway.激肽释放酶6通过PI3K/AKT/mTOR信号通路介导胃癌细胞的干性和代谢。
Oncol Lett. 2021 Dec;22(6):824. doi: 10.3892/ol.2021.13085. Epub 2021 Oct 12.
6
[Expressions of TGIF, MMP9 and VEGF proteins and their clinicopathological relationship in gastric cancer].[胃癌中TGIF、MMP9和VEGF蛋白的表达及其临床病理关系]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006 Feb;31(1):70-4.
7
TMEM119 promotes gastric cancer cell migration and invasion through STAT3 signaling pathway.跨膜蛋白119通过信号转导和转录激活因子3信号通路促进胃癌细胞的迁移和侵袭。
Onco Targets Ther. 2018 Sep 13;11:5835-5844. doi: 10.2147/OTT.S164045. eCollection 2018.
8
Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.miR-133a通过抑制IGF1R在胃癌中的肿瘤抑制作用。
World J Gastroenterol. 2015 Mar 14;21(10):2949-58. doi: 10.3748/wjg.v21.i10.2949.
9
ZNF139 promotes tumor metastasis by increasing migration and invasion in human gastric cancer cells.ZNF139 通过增加人胃癌细胞的迁移和侵袭促进肿瘤转移。
Neoplasma. 2014;61(3):291-8. doi: 10.4149/neo_2014_037.
10
HOXC6 promotes gastric cancer cell invasion by upregulating the expression of MMP9.HOXC6通过上调MMP9的表达促进胃癌细胞侵袭。
Mol Med Rep. 2016 Oct;14(4):3261-8. doi: 10.3892/mmr.2016.5640. Epub 2016 Aug 19.

引用本文的文献

1
KLK7, KLK10, and KLK11 in Papillary Thyroid Cancer: Bioinformatic Analysis and Experimental Validation.甲状腺乳头状癌中 KLK7、KLK10 和 KLK11:生物信息学分析和实验验证。
Biochem Genet. 2024 Dec;62(6):4446-4471. doi: 10.1007/s10528-024-10679-8. Epub 2024 Feb 5.
2
Long-Term Exposure to Supraphysiological Levels of Testosterone Impacts Rat Submandibular Gland Proteome.长期暴露于超生理水平的睾酮会影响大鼠下颌下腺蛋白质组。
Int J Mol Sci. 2023 Dec 31;25(1):550. doi: 10.3390/ijms25010550.
3
Identification and validation of key genes associated with pathogenesis and prognosis of gastric cancer.

本文引用的文献

1
A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering.通过组合工程开发的一种强力、抗蛋白水解的激肽释放酶相关肽酶 6(KLK6)抑制剂,用于癌症治疗。
J Biol Chem. 2018 Aug 17;293(33):12663-12680. doi: 10.1074/jbc.RA117.000871. Epub 2018 Jun 22.
2
Kallikrein-related peptidases in lung diseases.肺疾病中的激肽释放酶相关肽酶。
Biol Chem. 2018 Sep 25;399(9):959-971. doi: 10.1515/hsz-2018-0114.
3
Kallikrein-related peptidase 6 induces chemotherapeutic resistance by attenuating auranofin-induced cell death through activation of autophagy in gastric cancer.
鉴定和验证与胃癌发病机制和预后相关的关键基因。
PeerJ. 2023 Oct 16;11:e16243. doi: 10.7717/peerj.16243. eCollection 2023.
4
A KLK6 Activity-Based Probe Reveals a Role for KLK6 Activity in Pancreatic Cancer Cell Invasion.一种 KLK6 活性探针揭示了 KLK6 活性在胰腺癌细胞侵袭中的作用。
J Am Chem Soc. 2022 Dec 14;144(49):22493-22504. doi: 10.1021/jacs.2c07378. Epub 2022 Nov 22.
5
Remodelling of the tumour microenvironment by the kallikrein-related peptidases.激肽释放酶相关肽酶重塑肿瘤微环境。
Nat Rev Cancer. 2022 Apr;22(4):223-238. doi: 10.1038/s41568-021-00436-z. Epub 2022 Jan 31.
6
KLK8 promotes the proliferation and metastasis of colorectal cancer via the activation of EMT associated with PAR1.KLK8 通过激活与 PAR1 相关的 EMT 促进结直肠癌的增殖和转移。
Cell Death Dis. 2021 Sep 22;12(10):860. doi: 10.1038/s41419-021-04149-x.
7
Silencing of kallikrein-related peptidase 6 attenuates the proliferation, migration, and invasion of gastric cancer cells through inhibition of epithelial-mesenchymal transition.激肽释放酶相关肽酶6的沉默通过抑制上皮-间质转化减弱胃癌细胞的增殖、迁移和侵袭。
Exp Ther Med. 2021 Jul;22(1):770. doi: 10.3892/etm.2021.10202. Epub 2021 May 17.
8
KLK11 suppresses cellular proliferation via inhibition of Wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.KLK11通过抑制食管鳞状细胞癌中的Wnt/β-连环蛋白信号通路来抑制细胞增殖。
Am J Cancer Res. 2019 Oct 1;9(10):2264-2277. eCollection 2019.
激肽释放酶相关肽酶6通过激活自噬减弱金诺芬诱导的胃癌细胞死亡,从而诱导化疗耐药。
Oncotarget. 2016 Dec 20;7(51):85332-85348. doi: 10.18632/oncotarget.13352.
4
Gastric cancer.胃癌。
Lancet. 2016 Nov 26;388(10060):2654-2664. doi: 10.1016/S0140-6736(16)30354-3. Epub 2016 May 5.
5
KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes.KLK6调控的miRNA网络激活乳腺癌亚型中的致癌途径。
Mol Oncol. 2016 Aug;10(7):993-1007. doi: 10.1016/j.molonc.2016.03.008. Epub 2016 Apr 8.
6
Gastric cancer review.胃癌综述。
J Carcinog. 2014 Dec 19;13:14. doi: 10.4103/1477-3163.146506. eCollection 2014.
7
Kallikrein-related peptidase 6 (KLK6) expression in the progression of colon adenoma to carcinoma.组织激肽释放酶相关肽酶6(KLK6)在结肠腺瘤进展为癌过程中的表达
Biol Chem. 2014 Sep;395(9):1105-17. doi: 10.1515/hsz-2014-0166.
8
Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer.涉及 KLK4 的分子回路整合了前列腺癌中的雄激素和 mTOR 信号。
Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):E2572-81. doi: 10.1073/pnas.1304318110. Epub 2013 Jun 24.
9
Upregulation and secretion of kallikrein-related peptidase 6 (KLK6) in gastric cancer.胃癌中激肽释放酶相关肽酶6(KLK6)的上调与分泌
Tumour Biol. 2012 Jun;33(3):731-8. doi: 10.1007/s13277-011-0267-1. Epub 2012 Feb 29.
10
Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer.血管内皮生长因子在卵巢癌生长和腹膜转移中的意义。
Cancer Metastasis Rev. 2012 Jun;31(1-2):143-62. doi: 10.1007/s10555-011-9337-5.